	Development of a neoadjuvant chemotherapy efficacy prediction model for nasopharyngeal carcinoma integrating magnetic resonance radiomics and pathomics: a multi-center retrospective study. BMC Cancer Wang Y, Zhang H, Wang H, Hu Y, Wen Z, Deng H, Huang D, Xiang L, Zheng Y, Yang L, Su L, Li Y, Liu F, Wang P, Guo S, Pang H, Zhou P. PMID: 39639211 [PubMed - indexed for MEDLINE]
	Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein-Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma. Anticancer Res Vasudevan HN, Lazar AA, Reyes K, Rong DA, Arevalo S, Federman S, Chan JW, Chiu CY, Miller S, Yom SS. PMID: 39626922 [PubMed - indexed for MEDLINE]
	Effect of blood oxidative stress indicators on oral mucositis in patients undergoing radiotherapy for nasopharyngeal carcinoma. Eur J Med Res Pang H, Li S, Fu X, Wen S, Chen D, Sun X, Chen Y, Yang S. PMID: 39614382 [PubMed - indexed for MEDLINE]
	Clinical Study of Tuhuanglian Liquid Wet Compress on Acute Radiation Dermatitis of Nasopharyngeal Carcinoma. Crit Rev Biomed Eng Qiu S, Chen A, Li Q, Guo L, Cai J, Xue X. PMID: 39612268 [PubMed - indexed for MEDLINE]
	Predictors for Disease-Free and Progression-Free Survivals in Metabolic Responders and Non-Responder on Follow-Up 18FDG PET/CT after Chemoradiation in Patients With Nasopharyngeal Cancer. Asian Pac J Cancer Prev Fatima N, Zaman A, Azam SM, Shahid W, Zaman MU. PMID: 39611909 [PubMed - indexed for MEDLINE]
	(18)F-NaF uptake in skull-base bone as a predictor of treatment response in advanced nasopharyngeal carcinoma. Sci Rep Mu X, Li J, Huang J, Wang Z, Li Z, Li X, Jiang Y, Zhou Z, Fu W. PMID: 39604456 [PubMed - indexed for MEDLINE]
	Multifactorial clinical analysis of factors affecting necrosis of nasal septal mucosal flap after salvage surgery for recurrent nasopharyngeal carcinoma. Sci Rep Gong Q, Li H, Liu H, Shi Y. PMID: 39592834 [PubMed - indexed for MEDLINE]
	HAEMATOLOGICAL TOXICITIES OF GEMCITABINE PLUS CISPLATIN VERSUS FLUOROURACIL, CISPLATIN, PLUS DOCETAXEL FOLLOWED BY CONCURRENT CHEMORADIOTHERAPY IN LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA. J Ayub Med Coll Abbottabad Rehman A, Haider G, Ramchand A, Khan SN, Sehar S, Mahmood R, Khattak YR, Anaum, Siddiqa A, Aqeel MA. PMID: 39585250 [PubMed - indexed for MEDLINE]
	Nasopharyngeal stenosis in cats: a retrospective study of 21 cases comparing endoscopic and surgical treatment (2018-2022). J Feline Med Surg Champetier A, Lemetayer J, Ruel Y, Dossin O. PMID: 39540664 [PubMed - indexed for MEDLINE]
	The Treatment of Primary Lymphoepithelioma-Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma. Cancer Med Lin Q, Du M, Yan S, Zhang X, Li X, Zhang Y, Zhang S, Chen S, Song M. PMID: 39540315 [PubMed - indexed for MEDLINE]
	Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas. Ann Med Guo LF, Hong JG, Wang RJ, Chen GP, Wu SG. PMID: 39529559 [PubMed - indexed for MEDLINE]
	Role of PET/CT in improving the cost effectiveness of nimotuzumab in nasopharyngeal carcinoma. Acta Otorhinolaryngol Ital Fu XB, Li TT, Fei ZD, Chen CB. PMID: 39526766 [PubMed - indexed for MEDLINE]
	Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol Liu SL, Li XY, Yang JH, Wen DX, Guo SS, Liu LT, Li YF, Luo MJ, Xie SY, Liang YJ, Sun XS, Yang ZC, Lv XF, Luo DH, Li JB, Liu Q, Wang P, Guo L, Mo HY, Sun R, Yang Q, Lan KQ, Jia GD, Li R, Zhao C, Xu RH, Chen QY, Tang LQ, Mai HQ. PMID: 39522541 [PubMed - indexed for MEDLINE]
	Relationship between changes in nutritional status during treatment and overall survival of newly diagnosed nasopharyngeal carcinoma patients. Eur J Oncol Nurs Chang WP. PMID: 39520762 [PubMed - indexed for MEDLINE]
	Whether Primary Bone-Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?-A Large-Cohort Retrospective Study. Cancer Med Guo WP, Jia GD, Xie SY, Yu X, Meng XH, Tang LQ, Li XY, Luo DH. PMID: 39494716 [PubMed - indexed for MEDLINE]
	Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial. Oral Oncol Shang K, Li T, Chen Y, Luo X, Wu H, Zhou Y, Song J, Wu W, Li Y, Luo X, Chen X, Gong X, Zhao C, Li Z, Liu L, He Q, Long J, Jin F. PMID: 39488901 [PubMed - indexed for MEDLINE]
	Nasopharyngeal carcinoma-associated inflammatory cytokines: ongoing biomarkers. Front Immunol Liang C, Kan J, Wang J, Lu W, Mo X, Zhang B. PMID: 39483474 [PubMed - indexed for MEDLINE]
	Liquid biopsy with plasma Epstein-Barr virus DNA characterizes biological relapse for the prediction of cancer recurrence in non-disseminated nasopharyngeal carcinoma. Eur J Cancer Zhang Q, Zhu L, Lv W, Xu T, Shen C, Qian W, Liu P, Ying H, He X, Hu C, Zhou X, Lu X. PMID: 39486162 [PubMed - indexed for MEDLINE]
	Exploring the Relationship Between YAP (Yes-Associated Protein) and VEGF-A with Distant Metastasis in Nasopharyngeal Carcinoma. Asian Pac J Cancer Prev Rachmadi L, Linggodigdo M, Hasan F, Cahyanur R, Salamah T, Susanto YDB. PMID: 39471016 [PubMed - indexed for MEDLINE]
	Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature. Strahlenther Onkol Yuce Sari S, Yilmaz MT, Yazici G, Mohammadipour S, Ozyigit G, Gullu I, Cengiz M. PMID: 39455454 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 8346

Page 1 of 418



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy